NCT04389632 2026-03-16A Study of Sigvotatug Vedotin in Advanced Solid TumorsSeagen Inc.Phase 1 Recruiting1,006 enrolled
NCT04198766 2025-12-18Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)Inhibrx Biosciences, IncPhase 1/2 Active not recruiting296 enrolled
NCT04999761 2024-09-25AB122 Platform StudyTaiho Pharmaceutical Co., Ltd.Phase 1 Recruiting917 enrolled
NCT01047007 2023-09-21A Dose Escalation Study of Adavosertib(MK1775) in Combination With 5-FU or 5-FU/CDDP in Patients With Advanced Solid Tumor (1775-005Merck Sharp & Dohme LLCPhase 1 Terminated11 enrolled 10 charts
NCT02658214 2020-08-20Durvalumab and Tremelimumab in Combination With First-Line Chemotherapy in Advanced Solid TumorsAstraZenecaPhase 1 Completed32 enrolled
NCT00010023 2011-04-05Capecitabine Combined With Cisplatin in Treating Patients With Locally Advanced or Metastatic Solid TumorsNYU Langone HealthPhase 1 Completed